Acino International is a pharmaceutical company that holds patents for various drug delivery technologies. It focuses on modified release oral forms, oral dispersible forms, transdermal systems, and extended release parenterals. The company offers a portfolio of pharmaceutical products for cardiovascular system, musculo-skeletal system, nervous system, urology, antianemics, diabetes, endocrine therapy, respiratory system and others. Formerly known as Acino Holding AG, the company is based in Zurich, Switzerland.